Cargando…

The Significance of Normal Pretreatment Levels of CA125 (<35 U/mL) in Epithelial Ovarian Carcinoma

OBJECTIVE: To assess the association between normal CA125 levels at diagnosis of epithelial ovarian carcinoma (EOC) with prognostic factors and with outcome. METHODS: The study group consisted of histologically confirmed EOC patients with normal pretreatment CA125 levels, and the controls consisted...

Descripción completa

Detalles Bibliográficos
Autores principales:	Menczer, Joseph, Ben-Shem, Erez, Golan, Abraham, Levy, Tally
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Rambam Health Care Campus 2015
Materias:	Clinical Research in Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4327321/ https://www.ncbi.nlm.nih.gov/pubmed/25717387 http://dx.doi.org/10.5041/RMMJ.10180

Ejemplares similares

Neoadjuvant chemotherapy in ovarian, primary peritoneal and tubal carcinoma: can imaging results prior to interval debulking predict survival?
por: Menczer, Joseph, et al.
Publicado: (2011)

The prognostic value of pretreatment CA-125 levels and CA-125 normalization in ovarian clear cell carcinoma: a two-academic-institute study
por: Bai, Huimin, et al.
Publicado: (2016)

Prognostic relevance of high pretreatment CA125 levels in primary serous ovarian cancer
por: Bachmann, Robert, et al.
Publicado: (2021)

Prognostic relevance of high pretreatment CA125 levels in primary serous ovarian cancer
por: Bachmann, Robert, et al.
Publicado: (2021)

Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer
por: Chen, Jie-Ping, et al.
Publicado: (2019)

High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma
por: Morales-Vásquez, Flavia, et al.
Publicado: (2016)

CA125 in ovarian tumour tissue at second laparotomy.
por: Maughan, T. S., et al.
Publicado: (1989)

HE4, CA-125, and cystic ovarian mass
por: Wiwanitkit, Viroj
Publicado: (2012)

CA125 and Ovarian Cancer: A Comprehensive Review
por: Charkhchi, Parsa, et al.
Publicado: (2020)

Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response
por: Hamed, Elham O, et al.
Publicado: (2013)

Prognostic Significance of CA125 Dynamic Change for Progression Free Survival in Patients with Epithelial Ovarian Carcinoma
por: Li, Zemin, et al.
Publicado: (2020)

Prognostic Significance of Log(CA125)/PCI for the Resectability of Epithelial Ovarian Cancer: A Retrospective Study
por: He, Can, et al.
Publicado: (2020)

Clinical Significance of CA125 Level after the First Cycle of Chemotherapy on Survival of Patients with Advanced Ovarian Cancer
por: Lee, Maria, et al.
Publicado: (2016)

The significance of the change pattern of serum CA125 level for judging prognosis and diagnosing recurrences of epithelial ovarian cancer
por: Yang, Zhi-jun, et al.
Publicado: (2016)

Significance of the serum CA-125 level in intrauterine insemination cycles
por: Choe, Seung Ah, et al.
Publicado: (2011)

Clinical Significance of Serum CA-125 in Korean Females with Ascites
por: Bae, So Young, et al.
Publicado: (2013)

Clinical significance of serum CA125 in diffuse malignant mesothelioma
por: Cheng, Xu, et al.
Publicado: (2016)

Deciphering the Molecular Nature of Ovarian Cancer Biomarker CA125
por: Weiland, Florian, et al.
Publicado: (2012)

The Clinical Significance of CEA, CA19–9, and CA125 in Management of Appendiceal Adenocarcinoma
por: Yousef, Abdelrahman, et al.
Publicado: (2023)

CA19-9 as a marker for ovarian cancer: alone and in comparison with CA125.
por: Canney, P. A., et al.
Publicado: (1985)

The Value of CA 125 and CA72-4 in Management of Patients with Epithelial Ovarian Cancer
por: Fayed, Salah T., et al.
Publicado: (1998)

Complete Genome Sequence of Escherichia coli ML35
por: Casale, Angeline, et al.
Publicado: (2018)

Tumour-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA 125) in mucinous ovarian tumours.
por: Mogensen, O., et al.
Publicado: (1990)

Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer
por: Piatek, Szymon, et al.
Publicado: (2020)

Correlation analysis and clinical significance of CA125, HE4, DDI, and FDP in type II epithelial ovarian cancer
por: Qiao, Li, et al.
Publicado: (2020)

CA-125 Significance in Cirrhosis and Correlation with Disease Severity and Portal Hypertension
por: Collazos, Julio
Publicado: (2018)

Trial of isotretinoin and calcitriol monitored by CA 125 in patients with ovarian cancer.
por: Rustin, G. J., et al.
Publicado: (1996)

Combination of CA125 and RECAF biomarkers for early detection of ovarian cancer
por: Tcherkassova, Janneta, et al.
Publicado: (2011)

TB Peritonitis Mistaken for Ovarian Carcinomatosis Based on an Elevated CA-125
por: Boss, Joseph D., et al.
Publicado: (2012)

Is CA125 useful in monitoring patients with platinum-resistant ovarian cancer?
por: Rustin, G. J. S., et al.
Publicado: (2016)

Exosomal CA125 as A Promising Biomarker for Ovarian Cancer Diagnosis
por: Chen, Zhixiang, et al.
Publicado: (2020)

Combined Preoperative LMR and CA125 for Prognostic Assessment of Ovarian Cancer
por: Tang, Ying, et al.
Publicado: (2020)

VCAM-1 complements CA-125 in detecting recurrent ovarian cancer
por: Song, Jin, et al.
Publicado: (2023)

Ligand-based adoptive T cell targeting CA125 in ovarian cancer
por: Zhao, Haihong, et al.
Publicado: (2023)

Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma
por: Wang, Wei, et al.
Publicado: (2016)

Serum CA19‐9, CA‐125 and CEA as tumor markers for mucinous ovarian tumors
por: Lertkhachonsuk, Arb‐aroon, et al.
Publicado: (2020)

Investigational new insulin glargine 300 U/ml has the same metabolism as insulin glargine 100 U/ml
por: Steinstraesser, A, et al.
Publicado: (2014)

Primary ovarian adenosarcoma with elevated Ca-125 levels and normal ascitic fluid cytology: a case report and review of literature
por: Shakuntala, PN, et al.
Publicado: (2012)

An independent evaluation of the potential clinical usefulness of proposed CA-125 indices previously shown to be of prognostic significance in epithelial ovarian cancer.
por: Cruickshank, D. J., et al.
Publicado: (1992)

Retraction Note: The significance of the change pattern of serum CA125 level for judging prognosis and diagnosing recurrences of epithelial ovarian cancer
por: Yang, Zhi-jun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ajtrfeo3c7tbis60gu7k2t3q3f